ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Zacks: Analysts Anticipate Cardiome Pharma Corp (CRME) to Announce -$0.19 EPS
December 27, 2017Wall Street brokerages forecast that Cardiome Pharma Corp (NASDAQ:CRME) (TSE:COM) will announce ($0.19) earnings per share for the current fiscal quarter, according to Zacks Investment Research. -
Amarin (AMRN) Cut to “Sell” at Zacks Investment Research
December 26, 2017Zacks Investment Research lowered shares of Amarin (NASDAQ:AMRN) from a hold rating to a sell rating in a research report sent to investors on Wednesday.
Pharma Sources Insight January 2025
